ABSQUANT Trademark

Trademark Overview

On Wednesday, October 25, 2017, a trademark application was filed for ABSQUANT with the United States Patent and Trademark Office. The USPTO has given the ABSQUANT trademark a serial number of 87658791. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by Immatics Biotechnologies GmbH. The ABSQUANT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Development of cancer immunotherapy treatment options based on medical evaluation of individual patients

Research and development in the pharmaceutical and biotechnology fields; Medical research; Development of pharmaceutical preparations and medicines; Scientific research
absquant

General Information

Serial Number87658791
Word MarkABSQUANT
Filing DateWednesday, October 25, 2017
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6155993
Registration DateTuesday, September 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2020

Trademark Statements

Pseudo MarkABS QUANT
Goods and ServicesDevelopment of cancer immunotherapy treatment options based on medical evaluation of individual patients
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Medical research; Development of pharmaceutical preparations and medicines; Scientific research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 3, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 19, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmatics Biotechnologies GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTübingen 72076
DE
Party NameImmatics Biotechnologies GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTübingen 72076
DE
Party NameImmatics Biotechnologies GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTübingen 72076
DE

Trademark Events

Event DateEvent Description
Saturday, October 28, 2017NEW APPLICATION ENTERED
Friday, November 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 11, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 11, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 5, 2018ASSIGNED TO EXAMINER
Thursday, February 8, 2018PRIORITY ACTION WRITTEN
Thursday, February 8, 2018PRIORITY ACTION E-MAILED
Thursday, February 8, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, June 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 2, 2018ASSIGNED TO LIE
Wednesday, July 18, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 7, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 7, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 29, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, April 2, 2019NOTICE OF ALLOWANCE CANCELLED
Monday, April 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 17, 2019SU - NON-FINAL ACTION - WRITTEN
Wednesday, April 17, 2019NON-FINAL ACTION E-MAILED
Wednesday, April 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 23, 2019SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 23, 2019NON-FINAL ACTION E-MAILED
Wednesday, October 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 22, 2020TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, April 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 23, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 23, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 23, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 29, 2020ASSIGNED TO PETITION STAFF
Wednesday, June 3, 2020PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, June 3, 2020ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Wednesday, June 3, 2020ATTORNEY REVIEW COMPLETED
Wednesday, June 3, 2020NOA CANCELLED; REPUBLICATION REQUIRED
Wednesday, June 17, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 7, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, November 2, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 2, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 22, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

absquant research development medical pharmaceutical biotechnology fields scientific medicines preparations individual